Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29048254

Cc1ccc([C@@H]2CCON2)cn1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 6/20 0.33
KDM1A O60341 2/20 0.33
TNKS O95271 1/20 0.33
HDAC4 P56524 1/20 0.33
FFAR4 Q5NUL3 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
DGAT1 O75907 1/20 0.31
CCR2 P41597 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22256508 0.86 TNKS (0.34) TNKSCHRNB2CHRNA4
SCHEMBL22444813 0.86 TNKS (0.34) TNKSCHRNB2CHRNA4
SCHEMBL18921404 0.86 TNKS (0.34) TNKSCHRNB2CHRNA4
SCHEMBL29966596 0.86 TNKS (0.34) TNKSCHRNB2CHRNA4
SCHEMBL29641343 0.86 TNKS (0.34) TNKSCHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL18921382 0.86 JAK2 (0.32) KDM1ACHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL29966503 0.86 JAK2 (0.32) KDM1ACHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL30338680 0.85 GABRP (0.36) KDM1ATNKSPDE3BPDE3AKCNH2
Trifluoroacetic Acid SCHEMBL31205908 0.81 ABL1 (0.32) PDE3BPDE3ACHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL30338646 0.79 CHRNB2 (0.33) KDM1ACHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547281-A Isoxazolidines as RIPK1 inhibitors and uses thereof 赛诺菲 2023-08-04 CN disclosed
EP-4157835-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-04-05 EP disclosed